2020
DOI: 10.3390/cells9102300
|View full text |Cite
|
Sign up to set email alerts
|

How Altered Ribosome Production Can Cause or Contribute to Human Disease: The Spectrum of Ribosomopathies

Abstract: A number of different defects in the process of ribosome production can lead to a diversified spectrum of disorders that are collectively identified as ribosomopathies. The specific factors involved may either play a role only in ribosome biogenesis or have additional extra-ribosomal functions, making it difficult to ascribe the pathogenesis of the disease specifically to an altered ribosome biogenesis, even if the latter is clearly affected. We reviewed the available literature in the field from this point of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
39
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
2
2

Relationship

1
9

Authors

Journals

citations
Cited by 41 publications
(39 citation statements)
references
References 136 publications
(140 reference statements)
0
39
0
Order By: Relevance
“…Mutations in ribosomal proteins are most common in Diamond–Blackfan anemia (DBA), which is a syndrome of bone-marrow failure and elevated cancer incidence that apparently does not appear to resemble CS. However, the major difference between DBA and CS is the alteration or lack of the ribosomal proteins that might have extraribosomal functions suppressing cancer development [ 31 ]. Moreover, it has been shown that mutations in ribosomal proteins can lead to a reduced translational fidelity in DBA [ 32 ] but also in other developmental syndromes that resemble CS [ 33 ].…”
Section: Discussionmentioning
confidence: 99%
“…Mutations in ribosomal proteins are most common in Diamond–Blackfan anemia (DBA), which is a syndrome of bone-marrow failure and elevated cancer incidence that apparently does not appear to resemble CS. However, the major difference between DBA and CS is the alteration or lack of the ribosomal proteins that might have extraribosomal functions suppressing cancer development [ 31 ]. Moreover, it has been shown that mutations in ribosomal proteins can lead to a reduced translational fidelity in DBA [ 32 ] but also in other developmental syndromes that resemble CS [ 33 ].…”
Section: Discussionmentioning
confidence: 99%
“…Novel techniques to quantify small changes in rRNA PTM open up new possibilities for epitranscriptomics [ 28 , 29 ], which are expected to become increasingly complex when more types of RNA PTMs can be accurately quantified [ 30 , 31 ]. New insights in ribosome heterogeneity in stem cell differentiation [ 32 ], human diseases related to single gene defects (ribosomopathies [ 33 ]), or complex multifactorial diseases such as cancer [ 34 ] underline the importance of robust reporter assays to interrogate ribosome function. As such, the ribosome is now considered a drugable target for human disease [ 35 , 36 ].…”
Section: Introductionmentioning
confidence: 99%
“…Ribosomopathies are severe genetic diseases caused by mutations in genes involved in ribosome biogenesis and function and are, among others, associated with developmentally related skeletal malformations, caused by impairment of chondrogenic development of the growth plates ( Trainor and Merrill, 2014 ; Venturi and Montanaro, 2020 ). This indicates that chondrogenic differentiation is particularly susceptible to disturbances in ribosome protein translation activity.…”
Section: Discussionmentioning
confidence: 99%